Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/1996
12/04/1996CN1137292A Purification of vitamin-K dependent proteins by membrane chromatography
12/04/1996CN1137274A 6-oxo-nucleosides useful as immunosuppressants
12/04/1996CN1137040A New mercaptoalanoyldipeptide compounds process for their preparation and pharmaceutical compositions containign them
12/03/1996US5581476 Computer-based methods and articles of manufacture for preparing G-CSF analogs
12/03/1996US5580962 Purification of activated protein c by ion exchange chromatography to remove serum amyloid p, antibodies and thrombin-inhibitor complex, then inactivating viruses
12/03/1996US5580869 1N substituted pyrazino[2,3-c]-1,2,6-thiadiazine 2,2-dioxides
12/03/1996US5580789 Method for collecting blood
12/03/1996US5580755 Human pluripotent granulocyte colony-stimulating factor
12/03/1996US5580754 Culturing; transformation; transfection; isolation
12/03/1996US5580753 DNA encoding the human cytokine, interleukin-9
11/1996
11/28/1996WO1996037515A1 Process of high purity albumin production
11/28/1996WO1996037497A1 Low molecular weight bicyclic-urea type thrombin inhibitors
11/28/1996WO1996037492A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists
11/28/1996WO1996037489A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996WO1996037482A1 Improved isoxazoline fibrinogen receptor antagonists
11/28/1996WO1996024581A3 Derivatives of pyridil piperazine or pyridazinyl piperazyl, process for production thereof and medicaments containing these compounds
11/28/1996CA2222050A1 Improved isoxazoline fibrinogen receptor antagonists
11/28/1996CA2222041A1 1-benzoyl-2-(indolyl-3-alkyl)-piperazine derivatives as neurokinin receptor antagonists
11/28/1996CA2221980A1 Isoxazoline and isoxazole derivatives as integrin receptor antagonists
11/28/1996CA2218816A1 Low molecular weight bicyclic-urea type thrombin inhibitors
11/27/1996EP0743858A1 Antioxidants and intracellular glutathione raising agents for therapeutic treatments
11/27/1996EP0618973B1 t-PA SUBSTITUTION VARIANTS WITH IMPROVED FIBRIN-SPECIFICITY
11/27/1996CN1136808A Pseudodipeptide product having imidazole grouping and applications
11/27/1996CN1136567A Dioxide pyrrolo-pyrrolo derivatives
11/27/1996CN1136435A Application of pyromeconic acid and heteroside (erigeron glucoside) in pharmacy
11/27/1996CN1136434A Application of di-caffee acyl-oxy-quininic acid in pharmacy
11/26/1996US5578594 Anticoagulants
11/26/1996US5578574 Thrombin inhibitors or anticoagulants
11/26/1996US5578469 Process for preparing neotrehalose, and its uses
11/26/1996CA1338736C Microcrystals containing an active ingredient with affinity for phospholipids and at least one phospholipid; process for preparing the same
11/21/1996WO1996036713A2 Eck receptor ligands
11/21/1996WO1996036639A1 Amidine derivatives useful as anti-platelet aggregation inhibitors and vasodilators
11/21/1996WO1996036623A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996WO1996036327A1 Method of modulating microcirculation
11/21/1996WO1996036227A1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase
11/21/1996CA2220549A1 Amidine derivatives useful as anti-platelet aggregation inhibitors and vasodilators
11/21/1996CA2219129A1 Diaryl-5-oxygenated-2-(5h)-furanones as cox-2 inhibitors
11/21/1996CA2194692A1 Fibrin(ogen) degradation and clot lysis by fibrinolytic matrix metalloproteinase
11/20/1996EP0743320A2 Acyl guanidine and amidine prodrugs
11/20/1996EP0743304A1 4-(Arylaminomethylene)-2,4-dihydro-pyrazol-3-ones
11/20/1996EP0743302A2 Sulfonamide fibrinogen receptor antagonists
11/20/1996EP0742834A1 Method of preparing a viral vector by homologous intermolecular recombination
11/20/1996EP0742826A1 Multivariant il-3 hematopoiesis fusion protein
11/20/1996EP0742796A1 Il-3 variant hematopoiesis fusion protein
11/20/1996CN1135904A Oral liquid of shengxueyin
11/19/1996US5576447 Process for the preparation of amidino phenyl pyrrolidine β-alanine urea analogs
11/19/1996US5576444 Cyclic imino derivatives, processes for preparing them and pharmaceutical compositions containing these compounds
11/19/1996US5576343 Aromatic amidine derivatives and salts thereof
11/19/1996US5576334 Acylurea derivatives
11/19/1996US5576304 Antithrombotic composition
11/19/1996US5576294 Polypeptides as enzyme inhibitors
11/19/1996US5576291 Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
11/19/1996US5576193 Protein having human plasmin inhibiting activity
11/19/1996CA2176414A1 Acyl guanidine and amidine prodrugs
11/14/1996WO1996035416A1 Localized use of nitric oxideadducts to prevent internal tissue damage
11/13/1996EP0741576A1 Co-administration of interleukin-3 mutants with colony stimulating factors
11/13/1996CN1135760A Anti-thrombus active piptide and preparation method thereof
11/13/1996CN1135717A Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
11/13/1996CN1135485A 2,9-di-substituted pur-6-ones compound
11/13/1996CN1135358A Medicine for treatment of restenosis and arteriosclerosis
11/12/1996US5574656 System and method of automatically generating chemical compounds with desired properties
11/12/1996US5574168 1-(substituted benzyl)-3-(substituted aryl)-condensed pyrazole derivatives and processes of making the same
11/12/1996US5574019 Method of perfusing a primate
11/12/1996US5574016 Anticoagulants and cardiovascular disorders
11/12/1996US5573763 Family of CSF-l proteins
11/12/1996CA2040319C Sulfonylamino substituted bicyclyl hydroxamic acid derivatives
11/12/1996CA2039249C Sulfonylphenyl-.beta.-d-thioxylosides, their method of preparation and their use in therapeutics
11/12/1996CA1338698C Process for the preparation of a solution of high concentration of a protein having tissue plasminogen activator (t-pa) activity, a solution containing protein having t-pa activity and the use of the solution in human and veterinary medicine
11/07/1996WO1996034974A1 Low oxygen affinity mutant hemoglobin
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034890A2 Inhibitors of fibrin cross-linking and/or transglutaminases
11/07/1996WO1996034889A1 Storage stable hemoglobin solutions
11/07/1996WO1996034613A1 Endothelial lining effects and treatment of vasospastic disorders
11/07/1996CA2220268A1 Inhibitors of fibrin cross-linking and/or transglutaminases
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2216382A1 Storage stable hemoglobin solutions
11/06/1996EP0741133A2 Adhesion receptor antagonists
11/06/1996EP0741128A2 Sulphuric acid esters of sugar alcohols for the inhibition of the migration and proliferation of smooth muscle cells of the vascular walls
11/06/1996EP0740649A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
11/06/1996CA2174583A1 Sulfuric acid esters of sugar alcohols
11/05/1996US5571846 Method of inhibiting fibrosis
11/05/1996US5571844 Amidinophenylalanine derivatives, a process for their preparation, their use and compositions containing these as anticoagulants
11/05/1996US5571801 Plasma expander and blood substitute
11/05/1996US5571784 Use of VWF-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy
11/05/1996US5571508 Method for the treatment of thrombocytopenia and pharmaceutical compositions useful therefor
10/1996
10/31/1996WO1996033993A1 Antithrombotic amidinotetrahydropyridylalanine derivatives
10/31/1996WO1996033985A1 Piperidine derivatives as diuretic
10/31/1996WO1996033970A1 Substituted phenyl amidines, medicaments containing these compounds and process for producing them
10/31/1996DE19515500A1 Substituierte Phenylamidine, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Substituted phenylamidines, pharmaceutical compositions containing them and methods for their preparation
10/31/1996CA2219337A1 Substituted phenylamidines, pharmaceutical compositions containing these compounds and processes for preparing them
10/31/1996CA2219261A1 Antithrombotic amidinotetrahydropyridylalanine derivatives
10/30/1996EP0739886A2 Selective thrombin inhibitors
10/30/1996EP0739634A2 Porphyrin metal complex-albumin inclusion compound and oxygen carrier composition comprising the same
10/30/1996EP0739354A1 Compositions and methods using unbound mpl receptor for stimulating platelet production
10/30/1996CN1134706A Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same
10/30/1996CN1134705A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
10/30/1996CN1134696A Substituted 5-ring heterocycles, their preparation and their use
10/30/1996CN1134423A Adhesion receptor antagonists
10/30/1996CN1134417A 2,8-disubstituted quinazolinones
10/29/1996US5569675 Administering to treat blood disorders
1 ... 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 ... 671